GRAIL, LLC (GRAL NASDAQ) stock market data APIs
$38.5676
0.23(0.6%)
as of September 16, 2025
Try our APIs with
free plan!
GRAIL, LLC Financial Data Overview
Price chart is built with
Anychart
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, it develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Prev. Close
38.5676
Open
38.8021
High
39.4812
Low
38.3545
52 wk Range
12.33-63.99
Market Cap
1 418 M
Shares Outstanding
36 048 K
Revenue
134 M
EPS
-3.18
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with GRAIL, LLC (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get GRAIL, LLC data using free add-ons & libraries
Get GRAIL, LLC Fundamental Data
GRAIL, LLC Fundamental data includes:
- Net Revenue: 134 M
- EBITDA: -407 344 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-12
- EPS/Forecast: -3.56
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
GRAIL, LLC News
New
GRAIL, Inc. (GRAL): A Bull Case Theory
We came across a bullish thesis on GRAIL, Inc. on Valueinvestorsclub.com by skimmer610. In this article, we will summarize the bulls’ thesis on GRAL. GRAIL, Inc.'s share was trading at $32.42 as of ...
More Blood Tests for Cancer Hit the Market
The tests look for bits of altered DNA that cancer cells shed into the bloodstream. The screening technology holds hope of finding cancers early, when they might be cured. Continue Reading View comments
GRAIL (GRAL) Stock Surges 19% In Last Week
GRAIL recently announced a strong second-quarter financial performance, showing significant improvement in sales and a reduced net loss compared to the previous year. The company's market sentiment ap...
GRAIL shares validate InvestingPro's overvalued call with 41% decline
In February 2025, InvestingPro’s Fair Value model identified (NASDAQ:GRAL) as significantly overvalued at $55.02. Six months later, this analysis has proven remarkably accurate, with the stock decli...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
